iCardiac

Biotechnology ResearchPennsylvania, United States11-50 Employees

iCardiac is a biotechnology research company based in Philadelphia, Pennsylvania. It operates within the broader field of clinical trial data and technology, focusing on cardiac safety and related endpoints as part of its broader parent organization, ERT. The business operates as part of a global data and technology platform used to support clinical trials, with emphasis on reducing uncertainty and risk in study execution and patient safety, drawing on decades of experience in clinical and therapeutic contexts. The organization has an established presence through its association with ERT, which has pursued multiple acquisitions and integrations to expand its capabilities in data collection and trial oversight.

Customers in this space include pharmaceutical companies, biotechs, and contract research organizations that rely on endpoint data collection and patient safety measures to advance clinical programs. iCardiac contributes to this ecosystem by offering technology-enabled solutions that support monitoring, site optimization, patient engagement, and measurement of treatment efficacy, helping customers identify trial risks early and progress drug development with greater confidence. The company sits within the biotechnology research sector, positioned as a specialized provider within a network of related analytics, imaging, and safety services that collectively support regulatory-approved outcomes.

Sign up for free to view info

Email Format Employee directory